help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JUFFERMANS, N. P.
Right arrow Articles by van der POLL, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JUFFERMANS, N. P.
Right arrow Articles by van der POLL, T.

Am. J. Respir. Crit. Care Med., Volume 157, Number 4, April 1998, 1328-1331

Tumor Necrosis Factor and Interleukin-1 Inhibitors as Markers of Disease Activity of Tuberculosis

NICOLE P. JUFFERMANS, ANNELIES VERBON, SANDER J. H. van DEVENTER, HENK van DEUTEKOM, PETER SPEELMAN, and TOM van der POLL

Laboratory of Experimental Internal Medicine, the Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam, Amsterdam; and the Department of Tuberculosis, Municipal Health Service, Amsterdam, the Netherlands

Serum concentrations of tumor necrosis factor-alpha (TNF), interleukin (IL)-1beta , and their circulating inhibitors soluble TNF receptor type I (sTNFRI), type II (sTNFRII), IL-1 receptor antagonist (IL-1ra), and soluble IL-1 receptor type II (sIL-1RII) were measured for 123 patients with tuberculosis (TB) in various stages of disease, in persons who had been in close contact with patients with contagious pulmonary TB, and in healthy controls. Levels of sTNFRI, sTNFRII, and IL-1ra, but not of sIL-1RII, were elevated in patients with active TB compared with contacts and controls and declined during treatment. The concentrations of these mediators did not differ between patients with pulmonary and extrapulmonary TB. The levels of sTNFRI and IL-1ra were higher in patients with fever and anorexia. Neither TNF nor IL-1beta was detectable. We conclude that serum concentrations of sTNFRs I and II and IL-1ra may serve as markers of disease activity of TB. Sequential measurements of these cytokine inhibitors may be useful in the monitoring of antituberculous therapy.




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
R. Guler, M. L. Olleros, D. Vesin, R. Parapanov, and I. Garcia
Differential Effects of Total and Partial Neutralization of Tumor Necrosis Factor on Cell-Mediated Immunity to Mycobacterium bovis BCG Infection
Infect. Immun., June 1, 2005; 73(6): 3668 - 3676.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Bellehumeur, T. Collette, R. Maheux, J. Mailloux, M. Villeneuve, and A. Akoum
Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis
Hum. Reprod., May 1, 2005; 20(5): 1177 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
N. Benito, A. Moreno, X. Filella, J. M. Miro, J. Gonzalez, T. Pumarola, M. E. Valls, M. Luna, F. Garcia, A. Rano, et al.
Inflammatory Responses in Blood Samples of Human Immunodeficiency Virus-Infected Patients with Pulmonary Infections
Clin. Vaccine Immunol., May 1, 2004; 11(3): 608 - 614.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S.-W. Um, C.-M. Choi, C.-T. Lee, Y. W. Kim, S. K. Han, Y.-S. Shim, and C.-G. Yoo
Prospective Analysis of Clinical Characteristics and Risk Factors of Postbronchoscopy Fever
Chest, March 1, 2004; 125(3): 945 - 952.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. D. Aho, A. M. McNulty, and P. M. Coussens
Enhanced Expression of Interleukin-1{alpha} and Tumor Necrosis Factor Receptor-Associated Protein 1 in Ileal Tissues of Cattle Infected with Mycobacterium avium subsp. paratuberculosis
Infect. Immun., November 1, 2003; 71(11): 6479 - 6486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. Schwenk, L. Hodgson, C. F. Rayner, G. E Griffin, and D. C Macallan
Leptin and energy metabolism in pulmonary tuberculosis
Am. J. Clinical Nutrition, February 1, 2003; 77(2): 392 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer
Innate Immunity to Mycobacterium tuberculosis
Clin. Microbiol. Rev., April 1, 2002; 15(2): 294 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Marquet and E. Schurr
Genetics of Susceptibility to Infectious Diseases: Tuberculosis and Leprosy as Examples
Drug Metab. Dispos., April 1, 2001; 29(4): 479 - 483.
[Full Text]

Home page
 ChestHome page
T. C. Y. Tsao, J.-h. Hong, L.-F. Li, M.-J. Hsieh, S.-K. Liao, and K. S. S. Chang
Imbalances Between Tumor Necrosis Factor-{alpha} and Its Soluble Receptor Forms, and Interleukin-1{beta} and Interleukin-1 Receptor Antagonist in BAL Fluid of Cavitary Pulmonary Tuberculosis*
Chest, January 1, 2000; 117(1): 103 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. P. Juffermans, A. Verbon, S. J. H. van Deventer, H. van Deutekom, J. T. Belisle, M. E. Ellis, P. Speelman, and T. van der Poll
Elevated Chemokine Concentrations in Sera of Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Patients with Tuberculosis: a Possible Role for Mycobacterial Lipoarabinomannan
Infect. Immun., August 1, 1999; 67(8): 4295 - 4297.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
R. J. Wilkinson, P. Patel, M. Llewelyn, C. S. Hirsch, G. Pasvol, G. Snounou, R. N. Davidson, and Z. Toossi
Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1{beta} on Tuberculosis
J. Exp. Med., June 21, 1999; 189(12): 1863 - 1874.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  ATS 2008 State of the Art Course